BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 8521764)

  • 1. Famciclovir. A review of its pharmacological properties and therapeutic efficacy in herpesvirus infections.
    Perry CM; Wagstaff AJ
    Drugs; 1995 Aug; 50(2):396-415. PubMed ID: 8521764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Famciclovir: a review of its use in herpes zoster and genital and orolabial herpes.
    Simpson D; Lyseng-Williamson KA
    Drugs; 2006; 66(18):2397-416. PubMed ID: 17181386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valaciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in herpesvirus infections.
    Perry CM; Faulds D
    Drugs; 1996 Nov; 52(5):754-72. PubMed ID: 9118821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Famciclovir: review of clinical efficacy and safety.
    Cirelli R; Herne K; McCrary M; Lee P; Tyring SK
    Antiviral Res; 1996 Mar; 29(2-3):141-51. PubMed ID: 8739594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Once, twice, or three times daily famciclovir compared with aciclovir for the oral treatment of herpes zoster in immunocompetent adults: a randomized, multicenter, double-blind clinical trial.
    Shafran SD; Tyring SK; Ashton R; Decroix J; Forszpaniak C; Wade A; Paulet C; Candaele D
    J Clin Virol; 2004 Apr; 29(4):248-53. PubMed ID: 15018852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Famciclovir: a new systemic antiviral agent for herpesvirus infections.
    Stott GA
    Am Fam Physician; 1997 May; 55(7):2501-4. PubMed ID: 9166148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Famciclovir for the treatment of acute herpes zoster: effects on acute disease and postherpetic neuralgia. A randomized, double-blind, placebo-controlled trial. Collaborative Famciclovir Herpes Zoster Study Group.
    Tyring S; Barbarash RA; Nahlik JE; Cunningham A; Marley J; Heng M; Jones T; Rea T; Boon R; Saltzman R
    Ann Intern Med; 1995 Jul; 123(2):89-96. PubMed ID: 7778840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Famciclovir for treatment of herpesvirus infections.
    Luber AD; Flaherty JF
    Ann Pharmacother; 1996 Sep; 30(9):978-85. PubMed ID: 8876860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacological profile of famciclovir.
    Crumpacker C
    Semin Dermatol; 1996 Jun; 15(2 Suppl 1):14-26. PubMed ID: 8840412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in the treatment of herpesvirus infection: the role of famciclovir.
    Tyring SK
    Clin Ther; 1998; 20(4):661-70. PubMed ID: 9737826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral therapy of herpes simplex and varicella-zoster virus infections.
    Wutzler P
    Intervirology; 1997; 40(5-6):343-56. PubMed ID: 9675639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral antiviral therapy for prevention of genital herpes outbreaks in immunocompetent and nonpregnant patients.
    Le Cleach L; Trinquart L; Do G; Maruani A; Lebrun-Vignes B; Ravaud P; Chosidow O
    Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD009036. PubMed ID: 25086573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Famiciclovir therapy (famvir) for herpes simplex and herpes zoster infections.
    Tyring S
    Skin Therapy Lett; 2001 Nov; 6(12):1-2, 5. PubMed ID: 11753535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Famciclovir for the treatment of recurrent genital herpes: a clinical and pharmacological perspective.
    Vinh DC; Aoki FY
    Expert Opin Pharmacother; 2006 Nov; 7(16):2271-86. PubMed ID: 17059383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinic-initiated, twice-daily oral famciclovir for treatment of recurrent genital herpes: a randomized, double-blind, controlled trial.
    Sacks SL; Aoki FY; Martel AY; Shafran SD; Lassonde M
    Clin Infect Dis; 2005 Oct; 41(8):1097-104. PubMed ID: 16163627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valacyclovir in the treatment of herpes simplex, herpes zoster, and other viral infections.
    Wu JJ; Brentjens MH; Torres G; Yeung-Yue K; Lee P; Tyring SK
    J Cutan Med Surg; 2003; 7(5):372-81. PubMed ID: 14505192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valaciclovir: a review of its use in the management of herpes zoster.
    Ormrod D; Goa K
    Drugs; 2000 Jun; 59(6):1317-40. PubMed ID: 10882165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Famciclovir reduces viral mucosal shedding in HSV-seropositive persons.
    Leone P; Warren T; Hamed K; Fife K; Wald A
    Sex Transm Dis; 2007 Nov; 34(11):900-7. PubMed ID: 17538513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent clinical experience with famciclovir--a "third generation" nucleoside prodrug.
    Chakrabarty A; Tyring SK; Beutner K; Rauser M
    Antivir Chem Chemother; 2004 Sep; 15(5):251-3. PubMed ID: 15535046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral famciclovir for the suppression of recurrent genital herpes: a randomized controlled trial. Collaborative Famciclovir Genital Herpes Research Group.
    Diaz-Mitoma F; Sibbald RG; Shafran SD; Boon R; Saltzman RL
    JAMA; 1998 Sep; 280(10):887-92. PubMed ID: 9739972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.